EDAP TMS (EDAP) announced the publication of the full results from the HIFI study in the prestigious, peer-reviewed journal, European Urology, which has the highest impact factor amongst scientific ...
Non-inferior salvage treatment–free survival at 30 months favored HIFU (90%) versus salvage radical prostatectomy (86%), ...
LYON, France, November 19, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced a moderated scientific presentation of clinical data comparing Focal ...
MD Anderson at Cooper has expanded its prostate cancer treatment program with the addition of robotic high-intensity focused ultrasound, a groundbreaking therapy designed to treat tumors without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results